3-BroMo-9-Methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline
- $1033 - $2545
- Product name: 3-BroMo-9-Methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline
- CAS: 1429309-36-3
- MF: C11H12BrN3O
- MW: 282.14
- EINECS:
- MDL Number:MFCD22690750
- Synonyms:Pyrazolo[5,1-b]quinazoline, 3-bromo-5,6,7,8-tetrahydro-9-methoxy-
4 prices
Selected condition:
Brand
- Alichem
- Matrix Scientific
Package
- 250mg
- 500mg
- 1g
- ManufacturerAlichem
- Product number1429309363
- Product description3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline
- Packaging1g
- Price$1049.39
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101649
- Product description3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96%
- Packaging250mg
- Price$1033
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101649
- Product description3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96%
- Packaging500mg
- Price$1652
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number101649
- Product description3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96%
- Packaging1g
- Price$2545
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1429309363 | 3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline | 1g | $1049.39 | 2021-12-16 | Buy |
Matrix Scientific | 101649 | 3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96% | 250mg | $1033 | 2021-12-16 | Buy |
Matrix Scientific | 101649 | 3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96% | 500mg | $1652 | 2021-12-16 | Buy |
Matrix Scientific | 101649 | 3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo-[5,1-b]quinazoline 96% | 1g | $2545 | 2021-12-16 | Buy |
Properties
Density :1.73±0.1 g/cm3(Predicted)
pka :0.83±0.20(Predicted)
pka :0.83±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|